This research develops rapid, low-cost diagnostics for Mycoplasma genitalium, a difficult-to-detect, drug-resistant STI. By replacing PCR with LAMP-based methods, it enables faster, accessible testing using minimal equipment and visual readouts. The approach aims to improve early detection, treatment, and health equity, particularly in low-resource settings facing rising infection rates.